The Trader Harbor
  • Business
  • Politics
  • World News
  • Stocks
  • Business
  • Politics
  • World News
  • Stocks

The Trader Harbor

Politics

Joe Biden diagnosed with ‘aggressive form’ of prostate cancer with metastasis to the bone

by admin May 19, 2025
May 19, 2025
Joe Biden diagnosed with ‘aggressive form’ of prostate cancer with metastasis to the bone

Former President Joe Biden’s office confirmed on Sunday that he is undergoing treatment for prostate cancer. 

‘Last week, President Joe Biden was seen for a new finding of a prostate nodule after experiencing increasing urinary symptoms,’ Biden’s team shared in a statement. ‘On Friday, he was diagnosed with prostate cancer, characterized by a Gleason score of 9 (Grade Group 5) with metastasis to the bone.’ 

‘While this represents a more aggressive form of the disease, the cancer appears to be hormone-sensitive which allows for effective management. The President and his family are reviewing treatment options with his physicians,’ the statement continued.

This is a developing story. Please check back for updates. 

Stepheny Price is a writer for Fox News Digital and Fox Business. She covers topics including missing persons, homicides, national crime cases, illegal immigration, and more. Story tips and ideas can be sent to stepheny.price@fox.com

This post appeared first on FOX NEWS

0
FacebookTwitterGoogle +Pinterest
previous post
Rubio teases details of potential Trump, Putin in-person meeting after Russia-Ukraine ceasefire talks stall
next post
The Best Five Sectors, #19

Related Posts

Harris finally adds policy page to campaign website,...

September 9, 2024

Biden campaign accepts VP debate invitation for summer...

May 17, 2024

Top Hegseth advisor Dan Caldwell placed on administrative...

April 16, 2025

Experts warn Iran could have a nuclear bomb...

September 7, 2024

Rubio just got an additional job in Trump’s...

May 9, 2025

Fauci ripped over new paper criticizing Trump on...

December 1, 2024

White House to take questions on camera for...

July 3, 2024

Senate passes FISA surveillance tool renewal minutes after...

April 20, 2024

Trump cuts China tariff after Xi signals tougher...

October 30, 2025

Vance, Bondi, Patel to huddle at VP residence...

August 7, 2025

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Latest

    • The Real Drivers of This Market: AI, Semis & Robotics

      October 31, 2025
    • S&P 500 Breaking Out Again: What This Means for Your Portfolio

      October 31, 2025
    • Trump’s fire fades on Russia as he pulls troops, avoids pressing Xi on oil

      October 31, 2025
    • GOP lawmaker says backing Cuomo over ‘communist’ Mamdani a ‘no-brainer’

      October 31, 2025
    • Ultra-Orthodox protesters in Jerusalem rally over Israel’s draft exemption as clashes break out

      October 31, 2025
    • GOP blasts Jay Jones over disputed $500K claim, points to record of deception

      October 31, 2025

    Categories

    • Business (1,426)
    • Politics (4,896)
    • Stocks (1,741)
    • Uncategorized (45)
    • World News (1,419)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: TheTraderHarbor, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 thetraderharbor.com | All Rights Reserved